MEDICALRheumatologyHealth Calculator
🏥

HCQ Dosing

Young woman with newly diagnosed lupus starting HCQ

Did our AI summary help? Let us know.

Evidence-based calculations Used in clinical settings worldwide Regular monitoring recommended

Ready to run the numbers?

Why: This calculation helps assess important health parameters for clinical and personal wellness tracking.

How: Enter your values above and the calculator will apply validated formulas to compute your results.

Evidence-based calculationsUsed in clinical settings worldwide

Run the calculator when you are ready.

Understanding HCQ DosingUse the calculator below to check your health metrics

🦋 New SLE Diagnosis

Young woman with newly diagnosed lupus starting HCQ

Click to load

🦴 Long-term RA (8 years)

Patient on HCQ for 8 years - annual screening due

Click to load

👁️ High Retinal Risk

Multiple risk factors for HCQ retinopathy

Click to load

⚖️ Overweight Patient

Dose calculation using ideal body weight

Click to load

🩺 CKD Stage 3

Lupus patient with chronic kidney disease

Click to load

Clinical Scenarios

🦋 New SLE Diagnosis

New Start

Young woman with newly diagnosed lupus starting HCQ

🦴 Long-term RA (8 years)

Monitoring

Patient on HCQ for 8 years - annual screening due

👁️ High Retinal Risk

High Risk

Multiple risk factors for HCQ retinopathy

⚖️ Overweight Patient

Weight-Based

Dose calculation using ideal body weight

🩺 CKD Stage 3

Renal

Lupus patient with chronic kidney disease

Patient
Dosing
Renal
Retinal Risk
Safety

For informational purposes only — not medical advice. Consult a healthcare professional before acting on results.

🏥 Health Facts

— WHO

— CDC

What is Hydroxychloroquine?

Hydroxychloroquine (Plaquenil) is an antimalarial drug widely used for autoimmune conditions including systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sjögren syndrome. It has immunomodulatory, anti-inflammatory, and antithrombotic properties. The main concern with long-term use is irreversible retinal toxicity.

AAO 2016 Key Recommendations

1. Use ≤5 mg/kg ACTUAL body weight to minimize retinopathy risk
2. Screen annually after 5 years of use
3. Major risk factors: dose >5 mg/kg, duration >5 years, renal disease, tamoxifen use

Benefits

  • • Disease-modifying in SLE/RA
  • • Reduces flares and organ damage
  • • Cardiovascular protection
  • • Antithrombotic effects

Retinopathy Risk

  • • Dose-dependent (≤5 mg/kg)
  • • Duration-dependent (>5 years)
  • • Potentially irreversible
  • • Bull's eye maculopathy

Monitoring

  • • Baseline exam within 1 year
  • • Annual after 5 years
  • • SD-OCT + Visual fields
  • • Fundus autofluorescence

AAO 2016 Screening Guidelines

Duration/RiskScreening Recommendation
BaselineEye exam within first year of starting
Years 1-5 (low risk)No mandatory screening
Years 1-5 (high risk*)Annual screening recommended
>5 years (all patients)Annual screening MANDATORY

*High risk: >5 mg/kg/day, renal impairment, tamoxifen use, pre-existing maculopathy

👈 START HERE
⬅️Jump in and explore the concept!
AI

Related Calculators